Archived This bill is from the 117th Congress (2021–2022) and is no longer under active consideration.
Bills/H.R. 2891117th Congress

Preserve Access to Affordable Generics and Biosimilars Act

House: Reported
Companion bill: S. 1428(Related bill)
Cosponsors
6
Introduced
2021-04-28
Last action
2021-09-29

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

  2. House

    Committee Consideration and Mark-up Session Held.

  3. House

    Referred to the Subcommittee on Health.

  4. House

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Topics

Policy area

Sign in to view Hilltelligence’s potential-cosponsor analysis.